Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: BOSTON MEDICAL CENTER CORPORATION
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-08-01 to 2026-02-28
Current total value of award: $99921.01
Description: NICHD: R&D: A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION: NON-SEVERABLE